ÂÜÀòÂÒÂ×

Lars Thorsson is the current VP Clinical Development at Cantargia. Lars has extensive experience in the field, having worked at AstraZeneca for four years as the Clinical Program Director. There, they led the Clinical Program Team for inhaled bronchodilator and antiinflammatory projects for the treatment of COPD and asthma with projects ranging from PhI to PhIII. Thorsson has also worked as the Clinical Project Coordination Director at AstraZeneca R&D for three years.

Lars Thorsson has a PhD in medical science from Lund University and a PhD in biology/biological sciences, general from the same school.

Lars Thorsson works with Susanne Lagerlund - VP Regulatory Affairs, Ignacio Garcia-Ribas - CMO, and David Liberg - VP Cancer Research . Their manager is Göran Forsberg, CEO .